Mercy s 2013 Cancer Program Annual Report
|
|
- Camron McGee
- 6 years ago
- Views:
Transcription
1 Mercy s 2013 Cancer Program Annual Report Mercy Hospital & Medical Center is accredited by the Commission on Cancer as an Academic Comprehensive Cancer Program. This study directed by the Mercy s Cancer Committee relates to Standard 4.6: Assessment of Evaluation and Treatment Planning. Uterine cancer patients initially diagnosed at Mercy are compared to their national counterparts. Incidence, screening, demographics, stage at presentation, navigation, initial course of treatment, survival, nutrition and survivorship will be analyzed. Mercy Five Most Common Female Sites Mercy 2012 vs 2013 ACS Estimates 53% 4 29% 2 14% 8% 9% 6% 4% 3% 4% 2% 3% Breast Colon & Rectum Lung Uterus Lymphoma Kidney Incidence The American Cancer Society estimates that 49,560 1 new uterine cancers will be diagnosed in the U.S. in 2013, accounting for 3% of total estimated new cases. Uterine cancer is the most common gynecologic malignancy diagnosed in the United States. The incidence of uterine cancer has been rising and may be partially attributable to trends in both the aging of the population and increasing obesity. Uterine cancers accounted for 3% Mercy s analytic caseload in 2012 but preliminary registry data review exhibits an increase in 2013 incidence. 1 Cancer Facts & Figures 2013 pg 4 Uterus Race/Ethnicity Mercy 2007 to 2012 vs NCDB % Mercy 2007 to 2012 NCDB % 9% 6% 6% 5% White Black Hispanic API Demographics As seen above, over of women diagnosed with uterine cancer at Mercy Hospital are African American. This is more than 5 times the national statistics where Black women are through to represent between 7- of all new cases. Uterine cancer is also an area of significant health disparity, possibly due to factors such as delays in care, differences in surgery utilization, and more aggressive tumor types (4-5). This disparity persists even when controlled for stage and treatments. African American women are more likely to die from their disease; they represent 7% of all new cases, but 14% of deaths. According to national data, the 5-year survival rate for African American women is 7 compared to 90+% for white women. African American women with advanced stage disease have a 31% 5-year survival compared to 58% for white women (6). These statistics are compounded by higher rates of obesity, diabetes and cardiac disease in African American women. The demographic profile of the Mercy hospital cohort also likely affects difference in survival which will be reviewed later.
2 Uterus Stage at diagnosis Mercy 2007 to 2012 vs NCDB % 19% 2 9% 12% 5% 7% Stage I Stage II Stage III Stage IV Mercy 2007 to 2012 NCDB 2011 Stage at Diagnosis Nationally, the vast majority of patients diagnosed with uterine cancer with Stage I disease limited to the uterus while a smaller proportion will present with advanced stages: Stage III due to involvement of vagina, adnexa or regional lymph nodes or Stage IV involvement of upper abdomen, liver, lung or other distant sites. As seen in this chart, the women diagnosed at Mercy hospital are a high risk cohort in comparison as approximately 4 will present with advanced stage at initial diagnosis. Education of patients, primary care providers, emergency room providers about the symptoms of uterine cancer such as postmenopausal vaginal bleeding to trigger rapid referral for gynecologic or gynecologic oncology evaluation by endometrial biopsy will be emphasized to try to improve this disparity in our high risk population. Uterus Histology Mercy 2007 to 2012 vs NCBD % 73% 2 Adenocarcinoma Sarcoma 2% Mercy 2007 to 2012 NCBD 2011 Histology The distribution of histology types seen at Mercy Hospital compared to the NCDB demonstrates that there is a higher percentage of sarcomas which are a more aggressive type of uterine cancers associated with higher stage at presentation, higher recurrence risk and worse overall survival in compared to most of the adenocarcinoma cancers. This subtype is also found in increased frequency in African American women and may contribute to the racial disparity seen in overall survival.
3 Uterus Cancer Analytic Cases 2007 to 2012 BMI / Cardiovascular Disease BMI > 25 84% BMI > 25 with cardiovascular disease 45% BMI < 25 16% BMI < 25 with cardiovascular disease 58% Percentage of patients Co-morbid Conditions Most women with endometrial cancer are likely to be diagnosed early and cured of their disease (1). Despite a positive cancer outcome, the major risk factors for this cancer, which include obesity and diabetes, persist long after the cancer diagnosis, placing these women at high risk for future morbidity and mortality (2). Studies estimate that 60-8 percent of women are overweight or obese at the time of diagnosis. As seen above, the uterine cancer patients at Mercy have high rates of obesity and associated comorbid conditions such as cardiovascular disease. Such comorbid conditions are associated with poor quality of life, survival and can effect treatment options including surgery, chemotherapy and radiation. Mercy Uterus 2007 to 2012 Treatment by Stage percent of patients % 69% 67% 42% 17% 17% 17% 11% 8% 8% 8% 3% Stage I Stage II Stage III Stage IV Surgery Surgery & Adjuvant Chemo / Radiation No treatment Treatment 86% of Stage I patients, 83% of Stage II patients, 75% of Stage III and 92% of Stage IV patients received appropriate surgical intervention by our team of surgeons in the Gynecologic Oncology Service which is consistent with national standard of care. Surgery generally includes total hysterectomy, bilateral salpingo-oophorectomy and pelvic and/or para-aortic lymphadenectomy when clinically indicated. Stage IV patients may undergo more extensive debulking procedures with the goal for maximal cytoreduction to optimize survival. At Mercy Hospital, as many of the patients have high risk histology or higher stage disease, many will require adjuvant treatment with either chemotherapy and/or radiation. Their care is closely coordinated in a multidisciplinary fashion among the physicians in Gynecologic Oncology, Radiation Oncology and Medical Oncology. Challenging clinical cases can be presented at the hospital wide Mercy Hospital Tumor Board. A small but important proportion of patients had no treatment at Mercy hospital due to comorbid conditions, patient refusal, patient s electing for hospice care or loss of follow-up.
4 Uterus Observed Survival Cases Diagnosed in Mercy vs NCDB Cumulative Survival Rate % 87% 80 93% 85% 83% 8 % 60 71% 69% % Years from Diagnosis Mercy 2003 to 2006 NCDB 2003 to 2006 Mercy Observed Survival Cases diagnosed 2003 to 2006 Black vs All Other % 95% 78% 85% 85% 56% 79% 56% 79% 52% Black All other Survival Endometrial cancer is also an area of significant health disparity, possibly due to factors such as delays in care, differences in surgery utilization, and more aggressive tumor types (4-5). African American women are more likely to die from their disease; they represent 7% of all new cases, but 14% of deaths. According to national data, the 5-year survival rate for African American women is 7 compared to 90+% for white women. African American women with advanced stage disease have a 31% 5-year survival compared to 58% for white women (6). These statistics are compounded by higher rates of obesity, diabetes and cardiac disease in African American women. The survival of women with uterine cancer at Mercy is compared here to the NCDB data. As can be seen, after 2 years, the survival of patients treated at Mercy is approximately lower than the national statistics. The discrepancy in survival statistics is likely to be explained by Mercy s higher risk cohort of patients who as seen in prior graphs are more likely to be African American, to have more advanced stage at presentation, and higher risk histology. In addition, multiple comorbid conditions can adversely affect performance status and greatly limit treatment options in both the adjuvant and recurrent disease setting. Cancer Navigation The journey from the diagnosis of cancer through survivorship is challenging for any patient. Cancer Navigators guide patients through the continuum of cancer care. When utilized to their full potential Cancer Navigators function as a focal point for patients and their treating physicians. Beyond assisting patients in obtaining timely diagnostic imaging, consults and treatments, navigators can facilitate communication between treating physicians and between treating physicians and support services. The Patient Clinical Navigator in Gynecologic Oncology, Carol Newsom RN ( ) helps patient negotiate the challenges of multi-modal therapy that many of these patients are facing.
5 Nutrition Obesity and diabetes are well established independent risk factors for the development of endometrial cancer which is the most commonly seen subtype of uterine cancer. A recent review of over 33,000 endometrial cancer survivors demonstrated that cardiovascular disease was the leading cause of death in women with low grade early stage disease. For both high and low risk endometrial cancer patients, risk of death due to cardiovascular events was higher than risk of death from the cancer after 5 years (3). Thus, a new diagnosis of endometrial cancer becomes a compelling reason and teachable moment to promote nutrition, healthy behaviors, and weight loss in individual patients and their families. Healthy lifestyle change and interventions for reducing obesity should ideally encompass diet, exercise and behavioral change (7). Cancer survivors who are overweight or obese are in critical need of such interventions. Increasingly, advocates, patients and experts focus on survivorship issues that impact quality of life, health outcomes from co-morbid conditions after a cancer diagnosis and potential effects of obesity on cancer recurrence and survival (8-9). Obesity and weight reduction via improved diet and increased physical activity are challenging but concrete targets for cancer control and prevention efforts (10). These issues are especially important in our uterine cancer survivors. Counseling on nutrition and referral for further weight management options are actively promoted in the Gynecologic Oncology surveillance visits. During their visits, patients have the option to see one of our registered dieticians and/or to receive hands on education and written materials on diet and nutrition. Survivorship Though endometrial cancer has long been understood as one of the first cancers to be understood to be directly related to obesity, interventions targeting this group of women have been surprisingly limited compared. Pilot studies in understanding health-related behaviors and the feasibility and reproducibility of interventions are needed specifically amongst African American women with endometrial cancer. To specifically address the needs of our patient population of uterine cancers at Mercy Hospital, Dr. Nita Lee, one of the Gynecologic Oncology Physicians on staff at Mercy, has developed and been awarded a Cancer Control and Population Science Grant from the American Cancer Society, Illinois Division. The 2 year pilot program ( ), Endometrial Cancer Survivorship: Reducing Obesity Reducing Disparity focuses on using an endometrial cancer diagnosis as a teachable moment to address weight loss, nutrition, and healthy lifestyle among overweight and obese African American cancer survivors, their family members, and peers (social network). The program is a direct collaboration with the Mercy Center for Weight Management and recruits African American endometrial cancer survivors from both Mercy Hospital and University of Chicago Hospital to participate in the standard 16-week program offered at the Mercy Center for Weight Management. The research study will be a pilot intervention to recruit women, follow them throughout the course of this formal program and assess change throughout via both surveys and focus groups and through collection of bio-physical markers. The long term goal is to develop a sustainable program addressing critical intersection of obesity, racial disparities and cancer survivorship in women with a history of endometrial cancer. To learn more about this research program and efforts in Uterine Cancer Survivorship, Dr. Nita Lee or Carol Newsom, RN can be reached at Nita Karnik Lee MD, MPH Board Certified OB/GYN & Gynecologic Oncology Daniel Kacey, MD Cancer Committee Chairman Daniel Vicencio, MD Cancer Liaison Physician
6 References American Cancer Society. Cancer Facts and Figures Atlanta. American Cancer Society Calle E, Rodriguez C, Walker-Thurmond K, Thun M, Overweight, Obesity and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults, N Engl J Med, 2003; 348(17): Ward KK, Shah NR, Saenz CC et al. Cardiovascular disease is the leading cause of death among endometrial cancer patients, Gynecol Oncol, 2012; 126: Ueda S, Kapp DS, Cheung MK et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol Armstrong K, Randall T, Polsky D, Moye E, Silber J, Racial Differences in Surgeons and Hospitals for Endometrial Cancer Treatment, Medical Care. 2011; 49(2): Wright J, Fiorelli J, Schiff P, Burke W, Kansler A, Cohen C, Herzog T, Racial Disparities for Uterine Corpus Tumors, Cancer, 2009; 115: Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds). SEER Cancer Statistics Review, , National Cancer Institute. Bethesda, MD, based on November 2009 SEER data submission, posted to the SEER web site, Kirk S, Penney T, McHugh T, Sharma A, Effective weight management practice: a review of the lifestyle intervention evidence, Int J Obes Kushi L, Byers T, Doyle C, Bandera E, McCullough M, Gansler T, Andrews K, Thun M, American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer with Healthy Food Choices and Physical Activity, CA Cancer J Clin, 2006; 56: Doyle C, Kushi L, Byers T, Courneya K, Demark-Wahnefried W, Grant B, McTiernan A, Rock C, Thompson C, Gansler T, Andrews K, Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices, CA Cancer J Clin. 2006; 56: Demark-Wahnefried W, Platz EA, Ligibel JA et al. The role of obesity in Cancer Survival and Recurrence. Cancer Epidemiology, Biomarkers and Prevention. June 13, Online accessed doi: / epi Accessed June 19, Blanchard C, Courneya K, Stein K, Cancer Survivors Adherence to Lifestyle Behavior Recommendations and Associations with Health-Related Quality of Life: Results from the American Cancer Society s SCS-II, J Clin Oncol, (13): McTiernan A, Irwin M, von Gruenigen V, Weight, Physical Activity, Diet, and Prognosis in Breast and Gynecologic Cancers, J Clin Oncol, 2010; 28(26): Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women s Intervention Nutrition Study. J Natl Cancer Inst. 2006; 98: von Gruenigen V, Tian C, Frasure H, Waggoner S, Keys H, Barakat R, Treatment Effects, Disease Recurrence, and Survival in Obese Women with Early Endometrial Carcinoma, Cancer, 2006; 107(12): von Gruenigen VE, Waggoner SE, Frasure HE, Kavanagh MB, Janata JW, Rose PG, Courneya KS, Lifestyle Challenges in Endometrial Cancer Survivorship, Obstet Gynecol, 2011; 117(1):
Diet, Physical Activity, Weight & Cancer Survivorship: Perspectives from the NCI
Diet, Physical Activity, Weight & Cancer Survivorship: Perspectives from the NCI American Institute for Cancer Research Meeting October 21, 2010 Catherine M. Alfano, Ph.D. Program Director & Behavioral
More informationHealthcare Reform and Cancer Survivorship: Implications for Care & Research
Healthcare Reform and Cancer Survivorship: Implications for Care & Research Julia H. Rowland, Ph.D., Director Office of Cancer Survivorship National Cancer Institute National Institutes of Health DHHS
More informationLung and Bronchus Cancer Statistics in Virginia - Maps. July
July 2011 4 July 2011 5 July 2011 6 July 2011 7 Lung and Bronchus Cancer Statistics in Virginia - Notes Sources: Incidence and percent local staging (VA Cancer Registry); mortality (VDH Division of Health
More informationColorectal Cancer Statistics in Virginia - Maps. July
July 2011 5 July 2011 6 July 2011 7 July 2011 8 Colorectal Cancer Statistics in Virginia - Notes Sources: Incidence and percent local staging (VA Cancer Registry); mortality (VDH Division of Health Statistics);
More informationBreast Cancer Survivorship: Physical Activity
WORKING EVERYDAY TO PROVIDE THE HIGHEST QUALITY OF LIFE FOR PEOPLE WITH CANCER Breast Cancer Survivorship: What is the Role of Diet and Physical Activity WENDY DEMARK-WAHNEFRIED, PHD, RD PROFESSOR AND
More informationCancer of the Breast (Female) - Cancer Stat Facts
Page 1 of 9 Home Statistical Summaries Cancer Stat Facts Cancer of the Breast (Female) Cancer Stat Facts: Female Breast Cancer Statistics at a Glance At a Glance Estimated New Cases in 2016 % of All New
More informationPercent Surviving 5 Years 89.4%
Page 1 of 8 Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery Home Statistical Summaries Cancer Stat Fact Sheets Cancer of the Breast SEER Stat Fact Sheets: Breast
More informationMercy s Cancer Program 2014 Update
Mercy s Cancer Program 2014 Update Mercy Hospital & Medical Center is accredited Academic Comprehensive Cancer Program by the American College of Surgeon s Commission on Cancer. This study is directed
More informationKidney Cancer Causes, Risk Factors, and Prevention
Kidney Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for kidney cancer.
More informationTrends in Oncology Care. Challenges and Obstacles. Lawrence N. Shulman, MD Dana-Farber Cancer Institute Brigham and Women s Hospital
Trends in Oncology Care Challenges and Obstacles Lawrence N. Shulman, MD Dana-Farber Cancer Institute Brigham and Women s Hospital Navigation Through The Continuum of Cancer Care Education Screening Early
More informationProf. Dr. Aydın ÖZSARAN
Prof. Dr. Aydın ÖZSARAN Adenocarcinomas of the endometrium Most common gynecologic malignancy in developed countries Second most common in developing countries. Adenocarcinomas, grade 1 and 2 endometrioid
More informationImproving Representation of Diverse Patients in Clinical Trials
Improving Representation of Diverse Patients in Clinical Trials Coleman Obasaju, MD, PhD, Senior Medical Director US Medical Division, Oncology, Eli Lilly and Company Lilly s commitment to clinical diversity
More informationGynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy
Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Stephanie Yap, M.D. University Gynecologic Oncology Northside Cancer Institute Our Learning Objectives Review survival rates,
More information2016 Uterine Cancer Annual Report
2016 Uterine Cancer Annual Report Overview At Carolinas HealthCare System s Levine Cancer Institute, we offer comprehensive care focused on using the latest technology and innovative techniques in the
More informationThe ACA and Breast Cancer: Danger for Disparities Still Exists, Despite Law s Intentions
The ACA and Breast Cancer: Danger for Disparities Still Exists, Despite Law s Intentions Join the conversation on Twitter: #BreakingDownWalls Thursday, September 25, 2014 Presenters September 25, 2014
More informationOverview of All SEER-Medicare Publications
Overview of All SEER-Medicare Publications Outcomes Insights, Inc. Mark D. Danese, MHS, PhD Claire Cangialose February 22, 2017 Overview Information was extracted from the National Cancer Institute (NCI)
More informationOne Breast Cancer Annual Report
One 2015 Breast Cancer Annual Report One OVERVIEW The Breast Program at Carolinas HealthCare System s Levine Cancer Institute, offers comprehensive care. Patients with benign and malignant disease of the
More informationGreater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute
2008 ANNUAL REPORT Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute Cancer Registry Report The Cancer Data Management System/ Cancer Registry collects data on all types of cancer
More informationOverweight and obesity are significant factors in the incidence of acute and
Chapter 1 Introduction Overweight and obesity are significant factors in the incidence of acute and chronic health conditions, including cancer. The American Society of Clinical Oncology (ASCO) recognizes
More informationThe New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process
The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process Wednesday, April 29, 2009 at 11 AM Central M. Asa Carter, CTR Manager, Approvals and Standards
More informationFinancial Disclosure. Learning Objectives. Review and Impact of the NCDB PUF. Moderator: Sandra Wong, MD, MS, FACS, FASCO
Review and Impact of the NCDB PUF Moderator: Sandra Wong, MD, MS, FACS, FASCO Financial Disclosure I do not have personal financial relationships with any commercial interests Learning Objectives At the
More informationMichael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center
Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center 50 yo healthy postmenopausal female with BMI = 35 with screening PAP smear = AGUS. What is the next step? (1) Colposcopy
More informationEvolution of CoC within ACoS. American College of Surgeons Commission on Cancer Current Activities and Future Initiatives November 5,2005
American College of Surgeons Commission on Cancer Current Activities and Future Initiatives November 5,25 FREDERICK L. GREENE, MD Chair, Commission on Cancer Evolution of CoC within ACoS Two plans proposed
More informationEstimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004
MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer
More informationObjectives. Survivors. Survivorship in Cancer 7/20/2018. Over 15 million survivors in the U.S. Over 32 million worldwide. Oncology Survivorship Care
Survivorship in Cancer Oncology Survivorship Care Kathleen Martin, FNP-BC, AOCNP Objectives Define population of survivors of cancer Define the need for survivorship care Explain the purpose of survivorship
More information6/20/2012. Co-authors. Background. Sociodemographic Predictors of Non-Receipt of Guidelines-Concordant Chemotherapy. Age 70 Years
Sociodemographic Predictors of Non-Receipt of Guidelines-Concordant Chemotherapy - among Locoregional Breast Cancer Patients Under Age 70 Years Xiao-Cheng Wu, MD, MPH 2012 NAACCR Annual Conference June
More informationExceptional cancer care, close to home.
Exceptional cancer care, close to home. National Quality Performance Measures Presence Saint Joseph Hospital-Chicago and Presence Saint Francis joined forces in 2015 to become the Presence Lakeshore Region.
More informationUpdate on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact
Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most
More informationCommunity Comprehensive Cancer Program at Swedish Covenant Hospital 2009 Annual Report reflecting 2008 statistical data
Community Comprehensive Cancer Program at Swedish Covenant Hospital 2009 Annual Report reflecting 2008 statistical data Chairman s Message K. Joseph Philip, MD Section head, Medical Oncology/Hematology
More informationEarly Detection: Screening Guidelines
Early Detection: Screening Guidelines National Cancer Statistics 2015 National Cancer Statistics 1. 6 Million Cases Expected 589,430 Cancer Deaths expected 2015 Virginia Cancer Statistics: Projected cases:
More informationWhat Is Small Cell Lung Cancer?
About Small Cell Lung Cancer Overview If you have been diagnosed with small cell lung cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start.
More informationImpact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma
Hou et al. / Cancer Cell Research 3 (2014) 65-69 Cancer Cell Research Available at http:// http://www.cancercellresearch.org/ ISSN 2161-2609 Impact of Surgery Extent on Survival and Recurrence Rate of
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationStaging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationRelapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.9.3861 Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women RESEARCH ARTICLE Relapse Patterns and Outcomes Following
More informationChapter 13 Cancer of the Female Breast
Lynn A. Gloeckler Ries and Milton P. Eisner INTRODUCTION This study presents survival analyses for female breast cancer based on 302,763 adult cases from the Surveillance, Epidemiology, and End Results
More information1 Oregon Health & Science University, Portland, OR 2 Stritch School of Medicine, Loyola University Chicago, Chicago, IL
Current treatment practices for limited-stage small cell lung cancer: A survey of US radiation oncologists on the timing of thoracic radiotherapy with chemotherapy Matthew J. Farrell 1, Jehan Yahya 1,
More informationThe Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012
The Cancer Burden in California Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012 Goals Introduce you to the California Cancer Registry (CCR) Provide an
More informationCancer Facts & Figures for African Americans
Cancer Facts & Figures for African Americans What is the Impact of Cancer on African Americans in Indiana? Table 12. Burden of Cancer among African Americans Indiana, 2004 2008 Average number of cases
More informationEndometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines
Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Endometrial Cancer Emad R. Sagr, MBBS, FRCSC Consultant Gynecology Oncology Security forces Hospital, Riyadh Epidemiology
More informationENDOMETRIAL CANCER. Endometrial cancer is a great concern in UPDATE. For personal use only. Copyright Dowden Health Media
For mass reproduction, content licensing and permissions contact Dowden Health Media. UPDATE ENDOMETRIAL CANCER Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial
More informationTools, Reports, and Resources
Tools, Reports, and Resources What the National Cancer Database (NCDB) does for CoC-Accredited Programs By using the NCDB, CoC-accredited programs can proactively improve delivery and quality of care for
More informationGynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer
Gynecologic Oncology Pre invasive vulvar, vaginal, & cervical disease Vulvar Cervical Endometrial Uterine Sarcoma Fallopian Tube Ovarian GTD Gynecologic Oncologist Surgery Chemotherapy Radiation Therapy
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More information4/13/2010. Silverman, Buchanan Breast, 2003
Tailoring Breast Cancer Treatment: Has Personalized Medicine Arrived? Judith Luce, M.D. San Francisco General Hospital Avon Comprehensive Breast Care Center Outline First, treatment of DCIS Sorting risk
More informationLifestyle Factors and Cancer Survivorship: Observational Findings of Weight, Physical Activity, and Diet on Survival
Lifestyle Factors and Cancer Survivorship: Observational Findings of Weight, Physical Activity, and Diet on Survival Melinda L. Irwin, PhD, MPH Associate Professor of Epidemiology Yale School of Medicine
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More information2018 Hysterectomy Reimbursement Fact Sheet
2018 Hysterectomy Reimbursement Fact Sheet The information contained in this document is provided for informational purposes only and represents no statement, promise, or guarantee by Ethicon concerning
More informationChanging Practice: Provider-Patient Conversations about Physical Activity
Changing Practice: Provider-Patient Conversations about Physical Activity An Opportunity for Research Collaboration April 14, 2016 Kirsten A. Nyrop, PhD Research Assistant Professor Div. of Hematology-Oncology
More informationLymphedema In Ovarian Cancer Survivors: Assessing Diagnostic Methods And Risk Factors
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Public Health Theses School of Public Health January 2013 Lymphedema In Ovarian Cancer Survivors: Assessing Diagnostic Methods
More informationGREATER BALTIMORE MEDICAL CENTER SANDRA & MALCOLM BERMAN CANCER INSTITUTE
GREATER BALTIMORE MEDICAL CENTER SANDRA & MALCOLM BERMAN CANCER INSTITUTE CANCER REGISTRY REPORT The Cancer Data Management System/Cancer Registry collects data on all types of cancer diagnosed or treated
More information2015 Public Outcomes Report Cancer Program Practice Profile Reports 2013 Breast and Colon Cancer
As a Commission on Cancer (CoC)-accredited cancer program, HealthEast ensures that patients with cancer are treated according to nationally accepted measures. Measures for Quality of Cancer Care Each year,
More informationDAYS IN PANCREATIC CANCER
HOSPITAL AND MEDICAL CARE DAYS IN PANCREATIC CANCER Annals of Surgical Oncology, March 27, 2012 Casey B. Duncan, Kristin M. Sheffield, Daniel W. Branch, Yimei Han, Yong-Fang g Kuo, James S. Goodwin, Taylor
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer
THIS DOCUMENT North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT
More information2018 Texas Cancer Registry Annual Report
2018 Texas Cancer Registry Annual Report As Required by Texas Health and Safety Code Section 82.007 November 2018 Table of Contents Executive Summary... 1 1. Introduction... 2 2. Background... 3 Cancer
More informationAdjuvant Therapies in Endometrial Cancer. Emma Hudson
Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial
More informationObesity and Cancer Survivorship. Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona
Obesity and Cancer Survivorship Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona Objectives Describe the relationship between obesity, weight gain
More informationHemoglobin A1c and the relationship to stage and grade of endometrial cancer
DOI 10.1007/s00404-012-2455-7 GYNECOLOGIC ONCOLOGY Hemoglobin A1c and the relationship to stage and grade of endometrial cancer Erin E. Stevens Sarah Yu Melanie Van Sise Tana Shah Pradhan Vanessa Lee Michael
More information2016 Oncology Institute Annual Report
2016 Oncology Institute Annual Report Message from the Cancer Committee: On behalf of the Cancer Committee of The Methodist Hospitals, we are pleased to present to you our 2016 Oncology Institute Annual
More informationBringing the Fight to Cancer Annual Report
Bringing the Fight to Cancer. 21 Annual Report Quality Study Adherence to Adjuvant Systemic Therapy Following Primary Surgery in Stage II Breast Cancer Patients: Baylor Scott & White Medical Center Grapevine
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures. Because we are an accredited
More informationBREAST CANCER SITE STUDY REPORT By Robert O. Maganini, M.D., F.A.C.S. Breast Surgeon, Alexian Brothers Medical Group
BREAST CANCER SITE STUDY REPORT By Robert O. Maganini, M.D., F.A.C.S. Breast Surgeon, Alexian Brothers Medical Group Breast cancer is the most common cancer diagnosed in women around the world. In the
More informationOverview...3. Cancer Program.4. Breast Cancer with 5-year Survival Analysis...6. Systemic Therapy.7. Stage of Breast Cancer Diagnosed in
2011 Annual Report Table Of Contents Overview...3 Cancer Program.4 Breast Cancer with 5-year Survival Analysis...6 Systemic.7 Stage of Breast Cancer Diagnosed in 2008..8 Radiation and Systemic Only...9
More informationPredictors of Palliative Therapy Receipt in Stage IV Colorectal Cancer
Predictors of Palliative Therapy Receipt in Stage IV Colorectal Cancer Osayande Osagiede, MBBS, MPH 1,2, Aaron C. Spaulding, PhD 2, Ryan D. Frank, MS 3, Amit Merchea, MD 1, Dorin Colibaseanu, MD 1 ACS
More informationANNUAL REPORT. Figure 2 displays the distribution of the number of these diagnoses in 2013 by age (along the X axis) and by gender.
One ANNUAL REPORT Colorectal Cancer Colorectal cancer affects 14, Americans annually, making it the fourth most frequently diagnosed cancer in the US. It is also the second leading cause of cancer death
More information!"#$ Oncology Outcomes Report
!"#$ Oncology Outcomes Report The Cleveland Clinic Florida Cancer Institute is dedicated to the comprehensive care of patients with cancer. Oncologists collaborate with a variety of physicians across multiple
More informationChildhood Cancer Survivor Study Analysis Concept Proposal. Title: Analysis of Late Mortality by Treatment Era.
Childhood Cancer Survivor Study Analysis Concept Proposal Title: Analysis of Late Mortality by Treatment Era Working Group & Investigators: Greg Armstrong Todd Gibson Ann Mertens Wendy Leisenring YutakaYasui
More informationObjectives. Important Organizations 2/21/2015
Objectives Helene C. Geraci MN ARNP AOCNP Swedish Health Care Services Cancer Institute True Family Women s Cancer Center Know the criteria set by the COC for a survivorship program Learn components for
More informationOBESITY AND CANCER RISK
OBESITY AND CANCER RISK Obesity is a condition in which a person has an abnormally high and unhealthy proportion of body fat. According to the Kansas Behavioral Risk Factor Surveillance System, in 21,
More informationOBESITY AND CANCER RISK
OBESITY AND CANCER RISK Obesity is a condition in which a person has an abnormally high and unhealthy proportion of body fat. According to the Kansas Behavioral Risk Factor Surveillance System, in 212,
More informationGynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
More informationWhat is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*
What is the Impact of Cancer on African Americans in Indiana? Table 13. Burden of Cancer among African Americans Indiana, 2008 2012 Average number of cases per year Rate per 100,000 people* Number of cases
More information3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates
J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates Signs
More informationIndex. B Bilateral salpingo-oophorectomy (BSO), 69
A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell
More information2015 Patient Outcomes Report
2015 Patient Outcomes Report Message from the Breast Leadership Team and Cancer Committee: On behalf of the Breast Leadership Team and Cancer Committee of The Hospitals, we are pleased to present to you
More information6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention
6 Week Course Agenda Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention Lee-may Chen, MD Director, Division of Gynecologic Oncology Professor Department of Obstetrics, Gynecology
More information7. Cytoreductive surgery in endometrial cancer and uterine sarcomas
Transworld Research Network 37/661 (2), Fort P.O. Trivandrum-695 023 Kerala, India Cytoreductive Surgery in Gynecologic Oncology: A Multidisciplinary Approach, 2010: 123-151 ISBN: 978-81-7895-484-4 Editor:
More informationRacial and Ethnic Differences in Endometrial Cancer
Racial and Ethnic Differences in Endometrial Cancer BY ANNA B. BECKMEYER-BOROWKO B.S, University of Neuchatel in Switzerland, 2007 M.B.A., University of Neuchatel in Switzerland, 2009 M.P.H., University
More informationSurvival analysis of endometrial cancer patients with cervical stromal involvement
Original Article J Gynecol Oncol Vol. 25, No. 2:105-110 pissn 2005-0380 eissn 2005-0399 Survival analysis of endometrial cancer patients with cervical stromal involvement Jonathan E. Frandsen 1, William
More informationSFMC Breast Cancer Site Study: 2011
SFMC Breast Cancer Site Study: 2011 Introduction Breast cancer is the most frequently diagnosed cancer among American women, except for skin cancers. It is the second leading cause of cancer death in women,
More informationHUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014
HUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014 COMMISSION ON CANCER STANDARD 1.12 Hunt Cancer Institute Mission Statement To be first in the South Bay/Peninsula communities in the provision of quality
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND
More informationWhat Is Cancer of the Esophagus?
About Esophagus Cancer Overview and Types If you have been diagnosed with esophagus cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. What
More informationOne of the commonest gynecological cancers,especially in white Americans.
Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in
More informationBringing the Fight to Cancer Annual Report
Bringing the Fight to Cancer. 1 Annual Report Quality Study Adherence to Adjuvant Systemic Therapy Following Primary Surgery in Stage II Breast Cancer Patients: Baylor Scott & White Medical Center McKinney
More informationRETROSPECTIVE RECORD REVIEW OF PATIENTS DIAGNOSED WITH ENDOMETRIAL CANCER AND CARCINOSARCOMA AT RAHIMA
RETROSPECTIVE RECORD REVIEW OF PATIENTS DIAGNOSED WITH ENDOMETRIAL CANCER AND CARCINOSARCOMA AT RAHIMA MOOSA MOTHER AND CHILD HOSPITAL RECEIVING TREATMENT AT CHARLOTTE MAXEKE JOHANNESBURG ACADEMIC HOSPITAL
More informationGynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Controversies in Women s Health Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationGeneral Information. Please silence cell phones. Locations Restrooms to the left of the ballroom, or to your right by the elevators
American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without written permission of of the the American College College of Surgeons. of Surgeons.
More informationHealth Promotion, Screening, & Early Detection
OCN Test Content Outline 2018 Health Promotion, Screening, & Early Detection Kelley Blake MSN, RN, AOCNS, OCN UW Medicine/Valley Medical Center I. Care Continuum 19% A. Health promotion & disease prevention
More informationGynaecological Oncology Cases
Gynaecological Oncology Cases 1. Tamoxifen and the endometrium 2. Cancer and the older woman Dr Julie M Lamont Consultant Gynaecological Oncologist Epworth Freemasons Hospital 21 st April 2015 Mrs FS 66
More informationSlide 1. Slide 2. Slide 3 History of Nurse Navigator
Slide 1 The Nurse Navigators role in Early Stage Breast Cancer, and Development of Tailored Treatment Plan Laura Ochoa, RN, ANP-BC, Ph.D. Slide 2 Barnes Jewish Hospital at Washington University Slide 3
More informationIn this Update, I report on the latest US
UPDATE Gynecologic cancer Jason D. Wright, MD Dr. Wright is Sol Goldman Associate Professor, Chief of Division of Gynecologic Oncology, Vice Chair of Academic Affairs, Department of Obstetrics and Gynecology,
More informationAdvanced Pelvic Malignancy: Defining Resectability Be Aggressive. Lloyd A. Mack September 19, 2015
Advanced Pelvic Malignancy: Defining Resectability Be Aggressive Lloyd A. Mack September 19, 2015 CONFLICT OF INTEREST DECLARATION I have no conflicts of interest Advanced Pelvic Malignancies Locally Advanced
More informationBringing the Fight to Cancer Annual Report
Bringing the Fight to Cancer. 216 Annual Report Quality Study Adherence to Adjuvant System Therapy Following Primary Surgery in Stage II Breast Cancer Patients: Baylor Scott & White Medical Center Irving
More informationMontefiore Medical Center, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology and Women s Health, Bronx, NY, USA
Women s Health, Issues and Care Research Article Association of Obesity with Transtheoretical Stage of Change and Self Efficacy for Diet and Exercise in Racially and Ethnically Diverse Women with Endometrial
More informationColorectal Cancer Demographics and Survival in a London Cancer Network
Cancer Research Journal 2017; 5(2): 14-19 http://www.sciencepublishinggroup.com/j/crj doi: 10.11648/j.crj.20170502.12 ISSN: 2330-8192 (Print); ISSN: 2330-8214 (Online) Colorectal Cancer Demographics and
More informationBreast cancer followed by corpus cancer: Is there a higher risk for aggressive histologic subtypes?
Gynecologic Oncology 102 (2006) 508 512 www.elsevier.com/locate/ygyno Breast cancer followed by corpus cancer: Is there a higher risk for aggressive histologic subtypes? John K. Chan a,, Michael R. Manuel
More informationMPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?
MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion
More informationUTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS
Review Journal of Translational Medicine and Research, volume 19, no. 1-2, 2014 UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS N. Bacalbaæa 1, A. Traistaru 2, I. Bãlescu 3 1 Carol Davila University of Medicine
More information